Brendan Gilmore

Thomas Jefferson University

$831,520

Attributed

$3,326,079

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $702.8K · FY2020–25

$1M$750K$500K$250K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,326,079 · 1

By mechanism

R01$3,326,079 · 1

Top collaborators

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Detection”

Peter K Fritschel · California Institute Of Technology$78,820,000
Mark Marino · Venturewell$48,913,644
Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
Stuart Hellyar Hellyar$34,175,230
Bryan Faller · Decatur Memorial Hospital$29,346,991
Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000

Research focus

DetectionAntibiotic ResistanceAntibiotic TherapyAnimal ModelAntimicrobialAreaBacteriaBacterial AntigensAntibody Titer MeasurementAnti-Bacterial AgentsBoneCellsCellular BiologyChemistryChemokineClinically RelevantClinical MedicineClinical ProtocolsCombatComparison InterventionCoupledCytokineDendritic Cell ActivationDrug Resistant Pathogen

Grant awards (5)

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$638,200

R01 · FY2025 · AR

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$646,298

R01 · FY2024 · AR

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$676,113

R01 · FY2022 · AR

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$662,652

R01 · FY2021 · AR

Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium$702,816

R01 · FY2020 · AR